Brief: Mithra, Mayne Pharma Announce U.S. Launch Of HALOETTE

Mithra Pharmaceuticals SA

13/01/2023 06:35

Jan 13 (Reuters) - MITHRA PHARMACEUTICALS SA  MITRA.BR :
    * MAYNE PHARMA AND MITHRA ANNOUNCE US LAUNCH OF HALOETTE®, A
GENERIC VERSION OF NUVARING®
    * ACCORDING TO IQVIA, NUVARING® US BRAND AND GENERIC SALES
WERE
APPROXIMATELY USD 564 MILLION FOR 12 MONTHS ENDED NOVEMBER 2022
    * MAYNE PHARMA WILL PAY MITHRA A MILESTONE OF EUR 1.6
MILLION

Source text for Eikon:  ID:nNDL3yzg9G 
Further company coverage:  MITRA.BR   MYX.AX 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))